Breakthrough Cancer Research is delighted to announce that we are the Enterprise Partners in three of the successful Irish Research Council’s Enterprise Partnership Scheme awards announced by the Minister for Further and Higher Education, Research, Innovation and Science, Simon Harris TD, on August 17th

These are addressing (i) the psychosocial and spiritual concerns of individuals with terminal cancer, with Dr. Simon Dunne, Prof Pamela Gallagher and Ph.D. candidate Lucy Hayden in Dublin City University School of Psychology, (ii) and Uveal Melanoma Research with Prof Breandan Kennedy’s group, namely Dr. Husvinee Sundaramurthi (postdoctoral award) and Marzia Pendino (postgraduate award) in University College Dublin.  Ireland has one of the highest incidences of UM in the world.

The Enterprise Partnership Scheme has been operating for 15 years in the Irish research and innovation landscape and connects enterprises, early career researchers, and higher education institutions. These unique partnerships provide key benefits for all parties. For postgraduate and postdoctoral participants, the scheme builds links between researchers and the broader economy and society, which is key to driving future innovation.   Breakthrough looks forward to working with these groups to improve outcomes for those with cancer across the disease trajectory.

Title: Living and Dying Well – An Investigation of the Psychosocial and Spiritual Concerns of Patients with Terminal Cancer
PIs: Dr. Simon Dunne and Prof Pamela Gallagher. Ph.D. candidate Lucy Hayden, DCU

Title: Evaluation of the Therapeutic and Adverse Potential Cannabinoids in vision and Uveal Melanoma.
PI Prof Breandan Kennedy. PhD candidate: Marzia Pendino. UCD

Title: Evaluating anti-neoplastic activity of HDAC6 inhibitors in Uveal Melanoma cells and in zebrafish xenograft models of Uveal Melanoma 
PI Prof Breandan Kennedy. Postdoctoral awardee: Dr. Husvinee Sundaramurthi. UCD

Donate Now